Metformin therapy confers cardioprotection against the remodeling of gap junction in tachycardia-induced atrial fibrillation dog model
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 254, 117759
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81570310)
This publication has 69 references indexed in Scilit:
- Importance of atrial surface area and refractory period in sustaining atrial fibrillation: Testing the critical mass hypothesisThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Irregular Rhythm Adversely Influences Calcium Handling in Ventricular MyocardiumCirculation: Heart Failure, 2012
- Connexin Gene Transfer Preserves Conduction Velocity and Prevents Atrial FibrillationCirculation, 2012
- Inhibition of c-Src Tyrosine Kinase Prevents Angiotensin II–Mediated Connexin-43 Remodeling and Sudden Cardiac DeathJACC, 2011
- Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trialsDiabetes, Obesity and Metabolism, 2011
- Structural and Molecular Mechanisms of Gap Junction Remodeling in Epicardial Border Zone Myocytes following Myocardial InfarctionCirculation Research, 2009
- The tight junction protein CAR regulates cardiac conduction and cell–cell communicationJournal of Experimental Medicine, 2008
- Atrial Fibrillation Begets Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2008
- Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated SignalingDiabetes, 2008
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001